Cancer drugs in stock at private tertiary hospitals India 2021, by type

Published by A. Minhas, Feb 13, 2024
About 67 percent of the private tertiary hospitals across India had targeted therapy cancer drugs in stock in 2021. However, only about 57 percent of the private tertiary hospitals in the country had palliative care drugs for cancer in that time period.

Availability of cancer drugs at private tertiary hospitals across India in 2021, by type

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2022

Region

India

Survey time period

July 1, 2021 to September 30, 2021

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Cancer in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Cancer in the U.S.

Overview

5

Incidence rates

6

Death rates

8

Probability of surviving

5

Risk factors

8

Miscellaneous

3

Further related statistics

8

Further Content: You might find this interesting as well

Statistics

Topics

Cancer in ChinaMedical technology in ChinaCancer worldwidePharmaceutical industry in ChinaState of health in China
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.